SavedAdd your journal

Journals / Mucosa / 2026 / Cilt: 5 Sayı: 1

Chronic mucocutaneous candidiasis: a rare disease

Kronik mukokutanöz kandidiyazis: nadir bir hastalık

Tuğba Erat(Sanlıurfa Training and Research Hospital)0000-0003-2434-4134
İsa An(Sanlıurfa Training and Research Hospital)0000-0003-3366-4551
Murat Öztürk(Van Training and Research Hospital)0000-0002-4499-3724
Mustafa Aksoy(Harran University Medical Faculty)0000-0002-4303-699X
Erhan Ayhan(Gazi Yaşargil Trainning and Research Hospital)0000-0003-1416-2636
Egemen Uçan(Dicle University Medical Faculty)0000-0003-2131-7237
Journal
Mucosa
Pages
30–32
Publication Date
2022-05-31
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

The article type of "letter to editor" does not need to present an abstract for Mucosa.

📌 3 Key Takeaways

🎯
Objective & Hypothesis:The article type of "letter to editor" does not need to present an abstract for Mucosa.
📊
Key Findings & Data:The article type of "letter to editor" does not need to present an abstract for Mucosa.
💡
Conclusion & Impact:The article type of "letter to editor" does not need to present an abstract for Mucosa.
🔬Design:Editöre Mektup
📍Scope:Comprehensive Sample
⚙️Variables:kandidiyazis · mukokutanöz · vitiligo

Abstract

The article type of "letter to editor" does not need to present an abstract for Mucosa.

Özet

"Editöre mektup" makale türünde Mucosa için özet sunulmasına gerek yoktur.

🔖

Cite This Article

Erat, T., An, İ., Öztürk, M., Aksoy, M., Ayhan, E., Uçan, E. (2022). Chronic mucocutaneous candidiasis: a rare disease. Mucosa, Cilt: 5 Sayı: 1, 30–32. https://doi.org/10.33204/mucosa.956198

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (10)

  1. Shamriz O, Tal Y, Talmon A, Nahum A. Chronic mucocutaneous candidiasis in early life: Insights into immune mechanisms and novel targeted therapies. Front Immunol 2020;11:593289.
  2. Green L, Dolen WK. Chronic candidiasis in children. Curr Allergy Asthma Rep 2017;17:31.
  3. Veverka KK, Feldman SR. Chronic mucocutaneous candidiasis: what can we conclude about IL-17 antagonism? J Dermatolog Treat 2018;29:475-80.
  4. Khosravi AR, Mansouri P, Saffarian Z, Vahedi G, Nikaein D. Chronic mucocutaneous candidiasis, a case study and literature review. J Mycol Med 2018;28:206-10.
  5. Ostadi V, Sherkat R, Migaud M, et al. Functional analysis of two STAT1 gain-of-function mutations in two Iranian families with autosomal dominant chronic mucocutaneous candidiasis. Med Mycol 2021;59:180-8.
  6. Wang X, Netea MG, van de Veerdonk FL. Genetics of chronic mucocutaneous candidiasis. Immunogenetics of fungal diseases. Springer, 2017, p.85-103.
  7. Lehman H, Gordon C. The skin as a window into primary immune deficiency diseases: Atopic dermatitis and chronic mucocutaneous candidiasis. J Allergy Clin Immunol Pract 2019;7:788-98.
  8. Kirkpatrick CH. Chronic mucocutaneous candidiasis. Pediatr Infect Dis J 2001;20:197-206.
  9. van de Veerdonk FL, Netea MG. Treatment options for chronic mucocutaneous candidiasis. J Infect 2016;72:56-60.
  10. Egri N, Esteve-Sole A, Deya-Martinez A, et al. Primary immunodeficiency and chronic mucocutaneous candidiasis: pathophysiological, diagnostic, and therapeutic approaches. Allergol Immunopathol 2021;49: 118-27.